- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Nonparametric statistics.
Displaying page 1 of 1.
EudraCT Number: 2008-005315-18 | Sponsor Protocol Number: HMX3501 | Start Date*: 2009-07-21 | ||||||||||||||||
Sponsor Name:Mundipharma Research GmbH & Co. KG | ||||||||||||||||||
Full Title: A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio w... | ||||||||||||||||||
Medical condition: Moderate to severe chronic non-cancer or cancer pain with opioid induced constipation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) FI (Completed) GB (Completed) FR (Completed) NL (Completed) DE (Completed) AT (Completed) BE (Completed) DK (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003150-86 | Sponsor Protocol Number: V1.0 | Start Date*: 2019-09-20 |
Sponsor Name:Royal Cornwall Hospitals NHS Trust | ||
Full Title: A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses | ||
Medical condition: Actinic keratoses | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005558-21 | Sponsor Protocol Number: LUM001-401 | Start Date*: 2015-03-25 | |||||||||||
Sponsor Name:Lumena Pharmaceuticals LLC | |||||||||||||
Full Title: A Pilot, Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of LUM001, an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTi), in Patients with Primary Sclerosing Cholan... | |||||||||||||
Medical condition: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. PSC is characterized by inflammation and fibrosis of the intra- and extrahepatic biliary tree re... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004973-83 | Sponsor Protocol Number: S154.3.021 | Start Date*: 2007-05-02 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals. Inc. | |||||||||||||
Full Title: A Randomized, Multicenter, Double-blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients. | |||||||||||||
Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Prematurely Ended) CZ (Prematurely Ended) FI (Prematurely Ended) EE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
